# Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer

> **NCT00181168** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 63 (actual)

## Conditions studied

- Thyroid Cancer

## Interventions

- **DRUG:** Euthyroid Group

## Key facts

- **NCT ID:** NCT00181168
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** 2003-09
- **Final completion:** 2003-09
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2018-11-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00181168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00181168, "Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00181168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*